Physician profile
Yakov Levy
NPI 1154481885
$4,809.29
in general payments reported to CMS, 2019-2025
27 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $843 · 2020: $466 · 2021: $803 · 2022: $865 · 2023: $1,174 · 2024: $280 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,690 · Education: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,690.28 |
| Education | $141.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $952.20 | 2019-2024 | |
| Pfizer INC. | $585.31 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $566.03 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $469.51 | 2021-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $354.64 | 2021-2023 | |
| Therapeuticsmd, INC. | $328.75 | 2019-2022 | |
| Evofem Biosciences, INC. | $315.79 | 2020-2025 | Phexxi, Solosec, Phexx |
| Myovant Sciences INC. | $219.01 | 2021-2022 | |
| Lupin INC. | $216.37 | 2019-2021 | |
| Millicent US INC | $148.42 | 2019-2025 | Femring, Intrarosa, Femlyv |
| Scynexis, INC. | $140.96 | 2021-2022 | |
| Exeltis, USA INC. | $88.97 | 2019-2024 | Slynd |
| Agile Therapeutics, INC. | $57.22 | 2021-2022 | |
| Amgen INC. | $56.48 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $45.82 | 2023-2024 | Vivjoa |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $36.91 | 2019 | |
| Duchesnay USA Incorporated | $36.08 | 2019 | |
| Hologic Sales and Service, LLC | $24.52 | 2025 | Aptima |
| Ani Pharmaceuticals, INC. | $23.45 | 2024 | Purified Cortrophin Gel |
| Merck Sharp & Dohme LLC | $21.54 | 2020 | |
| Organon LLC | $21.43 | 2024 | |
| Vertical Pharmaceuticals, LLC | $18.75 | 2019 | |
| Galderma Laboratories, L.P. | $18.75 | 2023 | |
| Exact Sciences Corporation | $17.14 | 2024 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $16.99 | 2021 | |
| Coopersurgical, INC. | $15.20 | 2023 | Paragard T 380a |
| Roche Diagnostics Corporation | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yakov Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.